Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05590494 · ClinicalTrials.gov registry record · NA
Novel Treatment for Rotator Cuff Tears
A NA study of Supraspinatus Tear, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05590494: Recruiting NA study of Supraspinatus Tear, sponsored by Mayo Clinic.
NCT05590494 is a NA study of Supraspinatus Tear that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05590494, a NA study of Supraspinatus Tear, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The focus of this study is to examine changes in pain scores, strength, and range of motion over time following an ultrasonic tenotomy on a partial tear (\<50%) of the supraspinatus tendon of the rotator cuff.
Primary Outcome
Measured using a visual analog scale (VAS), used to measure subjective pain, rated from 0 (no pain) to 100 (most severe pain) at rest and during activity (previously painful activities)
Conditions Studied
Interventions
- PROCEDURE Ultrasonic tenotomy
Study Locations (1)
Wisconsin
- Mayo Clinic Health System - Onalaska - Onalaska
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2022-11-07 |
| Est. Completion | 2028-12 |
| Phase | NA |
What NCT05590494 shows while recruiting
NCT05590494 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Supraspinatus Tear appearing as the primary indexed condition, and to 1 intervention - of which Ultrasonic tenotomy is the first listed.
NCT05590494 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05590494 about?
NCT05590494 is a clinical study titled "Novel Treatment for Rotator Cuff Tears". The focus of this study is to examine changes in pain scores, strength, and range of motion over time following an ultrasonic tenotomy on a partial tear (\<50%) of the supraspinatus tendon of the rotator cuff.
What is the current status of trial NCT05590494?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2022-11-07. Estimated completion is 2028-12.
What conditions does trial NCT05590494 study?
This clinical trial studies the following conditions: Supraspinatus Tear.
What interventions are being tested in trial NCT05590494?
The interventions under investigation include: Ultrasonic tenotomy (PROCEDURE).
Who is sponsoring clinical trial NCT05590494?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05590494 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Supraspinatus Tear
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05590494's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI